U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Newberry SJ, Chung M, Anderson CAM, et al. Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jun. (Comparative Effectiveness Review, No. 206.)

Cover of Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks

Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks [Internet].

Show details

References

1.
Mortality GBD, Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117–71. doi: 10.1016/S0140-6736(14)61682-2. PMID: 25530442. [PMC free article: PMC4340604] [PubMed: 25530442] [CrossRef]
2.
World Health Organization. Guideline:: Sodium intake for adults and children World Health Organization (WHO). Geneva: 2012. [PubMed: 23658998]
3.
He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013(4):CD004937. doi: 10.1002/14651858.CD004937.pub2. PMID: 23633321. [PubMed: 23633321] [CrossRef]
4.
Aburto NJ, Ziolkovska A, Hooper L, et al Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:f1326. doi: 10.1136/bmj.f1326. PMID: 23558163. [PMC free article: PMC4816261] [PubMed: 23558163] [CrossRef]
5.
Institute of Medicine. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements National Academies Press. 2006.
6.
Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate The National Academies Press. Washington, D.C.: 2005.
7.
Institute of Medicine. Strategies to Reduce Sodium Intake in the United States The National Academies Press. Washington, D. C.: 2010.
8.
Institute of Medicine. Sodium Intake in Populations: Assessment of Evidence The National Academies Press. Washington, D. C.: 2013. [PubMed: 24851297]
9.
Whelton PK, Carey RM, Aronow WS, et al 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017 Nov 7 doi: 10.1016/j.jacc.2017.11.006. PMID: 29146535 [PubMed: 29146535] [CrossRef]
10.
Mozaffarian D, Fahimi S, Singh GM, et al Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014 Aug 14;371(7):624–34. doi: 10.1056/NEJMoa1304127. PMID: 25119608 [PubMed: 25119608] [CrossRef]
11.
He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013;4(1469-493X (Electronic)):Cd004937. doi: 10.1002/14651858.CD004937.pub2. PMID: 23633321. [PubMed: 23633321] [CrossRef]
12.
Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens. 2012 Jan;25(1941-7225 (Electronic)):1–15. doi: 10.1038/ajh.2011.210. PMID: 22068710. [PubMed: 22068710] [CrossRef]
13.
Aburto NJ, Ziolkovska A, Hooper L, et al Effect of lower sodium intake on health: systematic review and meta-analyses. Bmj. 2013;346(1756-1833 (Electronic)):f1326. doi: 10.1136/bmj.f1326. PMID: 23558163. [PMC free article: PMC4816261] [PubMed: 23558163] [CrossRef]
14.
2015 – 2020 Dietary Guidelines for Americans. 8th Edition. ed; U.S. Department of Health and Human Services and U.S. Department of Agriculture. Washington, D.C.: December 2015. http://health​.gov/dietaryguidelines​/2015/guidelines/
15.
Adler AJ, Taylor F, Martin N, et al Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014;12(1469-493X (Electronic)):Cd009217. doi: 10.1002/14651858.CD009217.pub3. PMID: 25519688 [PMC free article: PMC6483405] [PubMed: 25519688] [CrossRef]
16.
Singh GM, Danaei G, Farzadfar F, et al The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8(7):e65174. doi: 10.1371/journal.pone.0065174. PMID: 23935815 [PMC free article: PMC3728292] [PubMed: 23935815] [CrossRef]
17.
Ettehad D, Emdin CA, Kiran A, et al Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016 Mar 5;387(10022):957–67. doi: 10.1016/S0140-6736(15)01225-8. PMID: 26724178 [PubMed: 26724178] [CrossRef]
18.
Cobb LK, Anderson CA, Elliott P, et al Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation. 2014 Mar 11;129(10):1173–86. doi: 10.1161/CIR.0000000000000015. PMID: 24515991. [PubMed: 24515991] [CrossRef]
19.
Titze J. Estimating salt intake in humans: not so easy! Am J Clin Nutr. 2017 Jun;105(6):1253–4. doi: 10.3945/ajcn.117.158147. PMID: 28515066. [PubMed: 28515066] [CrossRef]
20.
Cogswell ME, Maalouf J, Elliott P, et al Use of Urine Biomarkers to Assess Sodium Intake: Challenges and Opportunities. Annu Rev Nutr. 2015;35:349–87. doi: 10.1146/annurev-nutr-071714-034322. PMID: 25974702. [PMC free article: PMC5497310] [PubMed: 25974702] [CrossRef]
21.
National Institutes of Health. Options for Consideration of Chronic Disease Endpoints for Dietary Reference Intakes (DRIs). 2015. https://ods​.od.nih.gov​/News/DRI_Workshop_March_10-11_2015​.aspx
22.
Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ Publication No. 10(14)-EHC063-EF. Rockville, MD: Agency for Healthcare Research and Quality. January 2014. Chapters available at: www​.effectivehealthcare.ahrq.gov.
23.
Harris JE, Raynor HA. Crossover Designs in Nutrition and Dietetics Research. J Acad Nutr Diet. 2017 Jul;117(7):1023–30. doi: 10.1016/j.jand.2017.03.017. PMID: 28479137 [PubMed: 28479137] [CrossRef]
24.
Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors: Protocol. Rockville, MD: Agency For Healthcare Research and Quality. https:​//effectivehealthcare​.ahrq.gov/ehc​/products/657/2428/sodium-potassium-protocol-170418.pdf. Accessed on July 24 2017.
25.
Higgins JP, Altman DG, Gotzsche PC, et al The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928. PMID: 22008217. [PMC free article: PMC3196245] [PubMed: 22008217] [CrossRef]
26.
Wells G, Shea B, O’Connell J, et al The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Ottawa, Ontario, Canada: The Ottawa Hospital; 2010. http://www​.ohri.ca/programs​/clinical_epidemiology/oxford.asp.
27.
Sidik K, Jonkman JN. Robust variance estimation for random effects meta-analysis. Comput Stat Data Anal. 2006;50(12):3681–701.
28.
Hartung J. An alternative method for meta-analysis. Biom J. 1999:901–16.
29.
IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014 Feb 18;14:25. doi: 10.1186/1471-2288-14-25. PMID: 24548571. [PMC free article: PMC4015721] [PubMed: 24548571] [CrossRef]
30.
Hartung J, Knapp G. A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat Med. 2001 Dec 30;20(24):3875–89. PMID: 11782040. [PubMed: 11782040]
31.
Crippa A, Orsini N. Multivariate Dose-Response Meta-Analysis: The dosresmeta R Package. Journal of Statistical Software. 2016;72(1):1–15.
32.
Liu Q, Cook NR, Bergström A, et al A two-stage hierarchical regression model for meta-analysis of epidemiologic nonlinear dose–response data. Computational Statistics & Data Analysis. 2009;53(12):4157–67.
33.
Berkman ND, Lohr KN, Ansari M, et al Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update. Methods Guide for Comparative Effectiveness Reviews (Prepared by the RTI-UNC Evidence-based Practice Center under Contract No. 290-2007-10056-I). AHRQ Publication No. 13(14)-EHC130-EF. Rockville, MD: Agency for Healthcare Research and Quality. November 2013.
34.
Alderman M, Sealey J, Cohen H, et al Urinary sodium excretion and myocardial infarction in hypertensive patients: a prospective cohort study. Am J Clin Nutr. 1997 Feb;65(2 Suppl):682S–6S. PMID: 9022565. [PubMed: 9022565]
35.
Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet. 1998 Mar 14;351(9105):781–5. doi: 10.1016/S0140-6736(97)09092-2. PMID: 9519949. [PubMed: 9519949] [CrossRef]
36.
Appel LJ, Espeland MA, Easter L, et al Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med. 2001 Mar 12;161(5):685–93. PMID: 11231700. [PubMed: 11231700]
37.
Ascherio A, Rimm EB, Giovannucci EL, et al A prospective study of nutritional factors and hypertension among US men. Circulation. 1992 Nov;86(5):1475–84. PMID: 1330360. [PubMed: 1330360]
38.
Cobiac L, Nestel PJ, Wing LM, et al A low-sodium diet supplemented with fish oil lowers blood pressure in the elderly. J Hypertens. 1992 Jan;10(1):87–92. PMID: 1312556. [PubMed: 1312556]
39.
Dodson PM, Beevers M, Hallworth R, et al Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. BMJ. 1989 Jan 28;298(6668):227–30. PMID: 2493869. [PMC free article: PMC1835532] [PubMed: 2493869]
40.
He J, Ogden LG, Vupputuri S, et al Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999 Dec 1;282(21):2027–34. PMID: 10591385. [PubMed: 10591385]
41.
He J, Whelton PK, Appel LJ, et al Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension. 2000 Feb;35(2):544–9. PMID: 10679495. [PubMed: 10679495]
42.
Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group. Arch Intern Med. 1990 Jan;150(1):153–62. PMID: 2404477. [PubMed: 2404477]
43.
Kagan A, Popper JS, Rhoads GG, et al Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke. 1985 May-Jun;16(3):390–6. PMID: 4002255. [PubMed: 4002255]
44.
Kumanyika SK, Hebert PR, Cutler JA, et al Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group. Hypertension. 1993 Oct;22(4):502–12. PMID: 8406655. [PubMed: 8406655]
45.
Mascioli S, Grimm R, Jr., Launer C, et al Sodium chloride raises blood pressure in normotensive subjects. The study of sodium and blood pressure. Hypertension. 1991 Jan;17(1 Suppl):I21–6. PMID: 1987006. [PubMed: 1987006]
46.
Morgan T, Anderson A. Sodium restriction can delay the return of hypertension in patients previously well-controlled on drug therapy. Can J Physiol Pharmacol. 1987 Aug;65(8):1752–5. PMID: 3319111. [PubMed: 3319111]
47.
Mulhauser I, Prange K, Sawicki PT, et al Effects of dietary sodium on blood pressure in IDDM patients with nephropathy. Diabetologia. 1996;39:212–9. [PubMed: 8635674]
48.
Richards AM, Nicholls MG, Espiner EA, et al Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension. Lancet. 1984 Apr 7;1(8380):757–61. PMID: 6143083. [PubMed: 6143083]
49.
Sacks FM, Svetkey LP, Vollmer WM, et al Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001 Jan 4;344(1):3–10. doi: 10.1056/NEJM200101043440101. PMID: 11136953. [PubMed: 11136953] [CrossRef]
50.
Schorr U, Distler A, Sharma AM. Effect of sodium chloride- and sodium bicarbonate-rich mineral water on blood pressure and metabolic parameters in elderly normotensive individuals: a randomized double-blind crossover trial. J Hypertens. 1996 Jan;14(1):131–5. PMID: 12013486. [PubMed: 12013486]
51.
The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992 Mar 4;267(9):1213–20. PMID: 1586398. [PubMed: 1586398]
52.
Erratum. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267:2330. [PubMed: 1586398]
53.
Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med. 1997 Mar 24;157(6):657–67. PMID: 9080920. [PubMed: 9080920]
54.
Tunstall-Pedoe H. Does dietary potassium lower blood pressure and protect against coronary heart disease and death? Findings from the Scottish Heart Health Study? Semin Nephrol. 1999 Sep;19(5):500–2. PMID: 10511390. [PubMed: 10511390]
55.
Tunstall-Pedoe H, Woodward M, Tavendale R, et al Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ. 1997 Sep 20;315(7110):722–9. PMID: 9314758. [PMC free article: PMC2127508] [PubMed: 9314758]
56.
Tuomilehto J, Jousilahti P, Rastenyte D, et al Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001 Mar 17;357(9259):848–51. doi: 10.1016/S0140-6736(00)04199-4. PMID: 11265954. [PubMed: 11265954] [CrossRef]
57.
Vollmer WM, Sacks FM, Ard J, et al Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001 Dec 18;135(12):1019–28. PMID: 11747380. [PubMed: 11747380]
58.
Ascherio A, Rimm EB, Hernan MA, et al Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation. 1998 Sep 22;98(12):1198–204. PMID: 9743511. [PubMed: 9743511]
59.
Bazzano LA, He J, Ogden LG, et al Dietary potassium intake and risk of stroke in US men and women: National Health and Nutrition Examination Survey I epidemiologic followup study. Stroke. 2001 Jul;32(7):1473–80. PMID: 11441188. [PubMed: 11441188]
60.
Bulpitt CJ, Ferrier G, Lewis PJ, et al Potassium supplementation fails to lower blood pressure in hypertensive patients receiving a potassium losing diuretic. Ann Clin Res. 1985;17(4):126–30. PMID: 3907484. [PubMed: 3907484]
61.
Chalmers J, Morgan T, Doyle A, et al Australian National Health and Medical Research Council dietary salt study in mild hypertension. J Hypertens Suppl. 1986 Dec;4(6):S629–37. PMID: 3475429. [PubMed: 3475429]
62.
Fang J, Madhavan S, Alderman MH. Dietary potassium intake and stroke mortality. Stroke. 2000 Jul;31(7):1532–7. PMID: 10884449. [PubMed: 10884449]
63.
Green DM, Ropper AH, Kronmal RA, et al Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology. 2002 Aug 13;59(3):314–20. PMID: 12177362. [PubMed: 12177362]
64.
Grimm RH, Kofron PM, Neaton JD, et al Effect of potassium supplementation combined with dietary sodium reduction on blood pressure in men taking antihypertensive medication. J Hypertens Suppl. 1988 Dec;6(4):S591–3. PMID: 3241259. [PubMed: 3241259]
65.
Gu D, He J, Wu X, et al Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial. J Hypertens. 2001 Jul;19(7):1325–31. PMID: 11446724. [PubMed: 11446724]
66.
Hajjar IM, Grim CE, George V, et al Impact of diet on blood pressure and age-related changes in blood pressure in the US population: analysis of NHANES III. Arch Intern Med. 2001 Feb 26;161(4):589–93. PMID: 11252120. [PubMed: 11252120]
67.
Hirvonen T, Pietinen P, Virtanen M, et al Nutrient intake and use of beverages and the risk of kidney stones among male smokers. Am J Epidemiol. 1999 Jul 15;150(2):187–94 PMID: 10412964. [PubMed: 10412964]
68.
Iso H, Stampfer MJ, Manson JE, et al Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999 Sep;30(9):1772–9. PMID: 10471422. [PubMed: 10471422]
69.
Khaw KT, Barrett-Connor E. Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med. 1987 Jan 29;316(5):235–40. doi: 10.1056/NEJM198701293160502. PMID: 3796701. [PubMed: 3796701] [CrossRef]
70.
Naismith DJ, Braschi A. The effect of low-dose potassium supplementation on blood pressure in apparently healthy volunteers. Br J Nutr. 2003 Jul;90(1):53–60. PMID: 12844375. [PubMed: 12844375]
71.
Obel AO. Placebo-controlled trial of potassium supplements in black patients with mild essential hypertension. J Cardiovasc Pharmacol. 1989 Aug;14(2):294–6. PMID: 2476604. [PubMed: 2476604]
72.
Patki PS, Singh J, Gokhale SV, et al Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study. BMJ. 1990 Sep 15;301(6751):521–3. PMID: 2207419. [PMC free article: PMC1663843] [PubMed: 2207419]
73.
Siani A, Strazzullo P, Russo L, et al Controlled trial of long term oral potassium supplements in patients with mild hypertension. Br Med J (Clin Res Ed). 1987 Jun 6;294(6585):1453–6. PMID: 3300841. [PMC free article: PMC1246609] [PubMed: 3300841]
74.
Svetkey LP, Yarger WE, Feussner JR, et al Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension. Hypertension. 1987 May;9(5):444–50. PMID: 3570421. [PubMed: 3570421]
75.
Whelton PK, Buring J, Borhani NO, et al The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995 Mar;5(2):85–95. PMID: 7795836. [PubMed: 7795836]
76.
Witteman JC, Willett WC, Stampfer MJ, et al A prospective study of nutritional factors and hypertension among US women. Circulation. 1989 Nov;80(5):1320–7. PMID: 2805268. [PubMed: 2805268]
77.
Thomas MC, Moran J, Forsblom C, et al The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011 Apr;34(4):861–6. doi: 10.2337/dc10-1722. PMID: 21307382. [PMC free article: PMC3064042] [PubMed: 21307382] [CrossRef]
78.
Adebamowo SN, Spiegelman D, Willett WC, et al Association between intakes of magnesium, potassium, and calcium and risk of stroke: 2 cohorts of US women and updated meta-analyses. Am J Clin Nutr. 2015 Jun;101(6):1269–77. doi: 10.3945/ajcn.114.100354. PMID: 25948665. [PMC free article: PMC4441806] [PubMed: 25948665] [CrossRef]
79.
Forman JP, Scheven L, de Jong PE, et al Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation. 2012 Jun 26;125(25):3108–16. doi: 10.1161/circulationaha.112.096115. PMID: 22711274. [PMC free article: PMC3804910] [PubMed: 22711274] [CrossRef]
80.
Mente A, O’Donnell M, Rangarajan S, et al Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2016 Jul 30;388(10043):465–75. doi: 10.1016/s0140-6736(16)30467-6. PMID: 27216139 [PubMed: 27216139] [CrossRef]
81.
Dunkler D, Dehghan M, Teo KK, et al Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med. 2013 Oct 14;173(18):1682–92. doi: 10.1001/jamainternmed.2013.9051. PMID: 23939297 [PubMed: 23939297] [CrossRef]
82.
Smyth A, Griffin M, Yusuf S, et al Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study. J Ren Nutr. 2016 Sep;26(5):288–98. doi: 10.1053/j.jrn.2016.01.016. PMID: 26975776 [PubMed: 26975776] [CrossRef]
83.
Miller ER, 3rd, Cooper LA, Carson KA, et al A Dietary Intervention in Urban African Americans: Results of the “Five Plus Nuts and Beans” Randomized Trial. Am J Prev Med. 2016 Jan;50(1):87–95. doi: 10.1016/j.amepre.2015.06.010. PMID: 26321012 [PMC free article: PMC4691550] [PubMed: 26321012] [CrossRef]
84.
Kitaoka K, Nagaoka J, Matsuoka T, et al Dietary intervention with cooking instructions and self-monitoring of the diet in free-living hypertensive men. Clin Exp Hypertens. 2013;35(2):120–7. doi: 10.3109/10641963.2012.702830. PMID: 22799766. [PubMed: 22799766] [CrossRef]
85.
Ekinci EI, Clarke S, Thomas MC, et al Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care. 2011 Mar;34(3):703–9. doi: 10.2337/dc10-1723. PMID: 21289228. [PMC free article: PMC3041211] [PubMed: 21289228] [CrossRef]
86.
Todd AS, Macginley RJ, Schollum JB, et al Dietary sodium loading in normotensive healthy volunteers does not increase arterial vascular reactivity or blood pressure. Nephrology (Carlton). 2012 Mar;17(3):249–56 doi: 10.1111/j.1440-1797.2011.01550.x. PMID: 22171802. [PubMed: 22171802] [CrossRef]
87.
Okayama A, Okuda N, Miura K, et al Dietary sodium-to-potassium ratio as a risk factor for stroke, cardiovascular disease and all-cause mortality in Japan: the NIPPON DATA80 cohort study. BMJ Open. 2016;6(7):e011632. doi: 10.1136/bmjopen-2016-011632. PMID: 27412107. [PMC free article: PMC4947715] [PubMed: 27412107] [CrossRef]
88.
Haring B, Wang W, Lee ET, et al Effect of dietary sodium and potassium intake on left ventricular diastolic function and mass in adults</=40 years (from the Strong Heart Study). Am J Cardiol. 2015 May 1;115(9):1244–8. doi: 10.1016/j.amjcard.2015.02.008. PMID: 25769626 [PMC free article: PMC4405184] [PubMed: 25769626] [CrossRef]
89.
Becerra-Tomas N, Guasch-Ferre M, Quilez J, et al Effect of Functional Bread Rich in Potassium, gamma-Aminobutyric Acid and Angiotensin-Converting Enzyme Inhibitors on Blood Pressure, Glucose Metabolism and Endothelial Function: A Double-blind Randomized Crossover Clinical Trial. Medicine (Baltimore). 2015 Nov;94(46):e1807. doi: 10.1097/md.0000000000001807. PMID: 26579797 [PMC free article: PMC4652806] [PubMed: 26579797] [CrossRef]
90.
Nakano M, Eguchi K, Sato T, et al Effect of Intensive Salt-Restriction Education on Clinic, Home, and Ambulatory Blood Pressure Levels in Treated Hypertensive Patients During a 3-Month Education Period. J Clin Hypertens (Greenwich). 2016 May;18(5):385–92. doi: 10.1111/jch.12770. PMID: 26732187. [PMC free article: PMC8031489] [PubMed: 26732187] [CrossRef]
91.
Matthesen SK, Larsen T, Vase H, et al Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans. Scand J Clin Lab Invest. 2012 Feb;72(1):78–86. doi: 10.3109/00365513.2011.635216. PMID: 22149452. [PubMed: 22149452] [CrossRef]
92.
Morikawa N, Yamasue K, Tochikubo O, et al Effect of salt reduction intervention program using an electronic salt sensor and cellular phone on blood pressure among hypertensive workers. Clin Exp Hypertens. 2011;33(4):216–22. doi: 10.3109/10641963.2011.583966. PMID: 21699447 [PubMed: 21699447] [CrossRef]
93.
Hwang JH, Chin HJ, Kim S, et al Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial. Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2059–69. doi: 10.2215/cjn.01310214. PMID: 25332317. [PMC free article: PMC4255393] [PubMed: 25332317] [CrossRef]
94.
Vongpatanasin W, Peri-Okonny P, Velasco A, et al Effects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive Subjects. Am J Cardiol. 2016 Sep 15;118(6):849–53. doi: 10.1016/j.amjcard.2016.06.041. PMID: 27448942 [PMC free article: PMC5021576] [PubMed: 27448942] [CrossRef]
95.
Kwakernaak AJ, Krikken JA, Binnenmars SH, et al Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial. Lancet Diabetes Endocrinol. 2014 May;2(5):385–95. doi: 10.1016/s2213-8587(14)70030-0. PMID: 24795252 [PubMed: 24795252] [CrossRef]
96.
Pinjuh Markota N, Rumboldt M, Rumboldt Z. Emphasized warning reduces salt intake: a randomized controlled trial. J Am Soc Hypertens. 2015 Mar;9(3):214–20. doi: 10.1016/j.jash.2014.12.022. PMID: 25659228. [PubMed: 25659228] [CrossRef]
97.
Pfister R, Michels G, Sharp SJ, et al Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC-Norfolk study. Eur J Heart Fail. 2014 Apr;16(4):394–402. doi: 10.1002/ejhf.56. PMID: 24464931. [PubMed: 24464931] [CrossRef]
98.
Stolarz-Skrzypek K, Kuznetsova T, Thijs L, et al Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. Jama. 2011 May 4;305(17):1777–85. doi: 10.1001/jama.2011.574. PMID: 21540421. [PubMed: 21540421] [CrossRef]
99.
Sarkkinen ES, Kastarinen MJ, Niskanen TH, et al Feasibility and antihypertensive effect of replacing regular salt with mineral salt - rich in magnesium and potassium- in subjects with mildly elevated blood pressure. Nutr J. 2011;10:88. doi: 10.1186/1475-2891-10-88. PMID: 21888642 [PMC free article: PMC3175151] [PubMed: 21888642] [CrossRef]
100.
Bongard V, Arveiler D, Dallongeville J, et al Food groups associated with a reduced risk of 15-year all-cause death. Eur J Clin Nutr. 2016 Jun;70(6):715–22. doi: 10.1038/ejcn.2016.19. PMID: 26931670. [PubMed: 26931670] [CrossRef]
101.
Barros CL, Sousa AL, Chinem BM, et al Impact of light salt substitution for regular salt on blood pressure of hypertensive patients. Arq Bras Cardiol. 2015 Feb;104(2):128–35. doi: 10.5935/abc.20140174. PMID: 25409877. [PMC free article: PMC4375656] [PubMed: 25409877] [CrossRef]
102.
Zhou B, Webster J, Fu LY, et al Intake of low sodium salt substitute for 3years attenuates the increase in blood pressure in a rural population of North China - A randomized controlled trial. Int J Cardiol. 2016 Jul 15;215:377–82. doi: 10.1016/j.ijcard.2016.04.073. PMID: 27128565 [PubMed: 27128565] [CrossRef]
103.
Sluijs I, Czernichow S, Beulens JW, et al Intakes of potassium, magnesium, and calcium and risk of stroke. Stroke. 2014 Apr;45(4):1148–50. doi: 10.1161/strokeaha.113.004032. PMID: 24519410 [PubMed: 24519410] [CrossRef]
104.
Buendia JR, Bradlee ML, Daniels SR, et al Longitudinal effects of dietary sodium and potassium on blood pressure in adolescent girls. JAMA Pediatr. 2015 Jun;169(6):560–8 doi: 10.1001/jamapediatrics.2015.0411. PMID: 25915457. [PubMed: 25915457] [CrossRef]
105.
Krupp D, Shi L, Remer T. Longitudinal relationships between diet-dependent renal acid load and blood pressure development in healthy children. Kidney Int. 2014 Jan;85(1):204–10. doi: 10.1038/ki.2013.331. PMID: 24025638. [PubMed: 24025638] [CrossRef]
106.
Zhou B, Wang HL, Wang WL, et al Long-term effects of salt substitution on blood pressure in a rural north Chinese population. J Hum Hypertens. 2013 Jul;27(7):427–33. doi: 10.1038/jhh.2012.63. PMID: 23254595. [PubMed: 23254595] [CrossRef]
107.
Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014 Mar 4;129(9):981–9. doi: 10.1161/circulationaha.113.006032. PMID: 24415713 [PMC free article: PMC4181831] [PubMed: 24415713] [CrossRef]
108.
Larsson SC, Virtamo J, Wolk A. Potassium, calcium, and magnesium intakes and risk of stroke in women. Am J Epidemiol. 2011 Jul 1;174(1):35–43. doi: 10.1093/aje/kwr051. PMID: 21540318. [PubMed: 21540318] [CrossRef]
109.
Krupp D, Shi L, Egert S, et al Prospective relevance of fruit and vegetable consumption and salt intake during adolescence for blood pressure in young adulthood. Eur J Nutr. 2015 Dec;54(8):1269–79. doi: 10.1007/s00394-014-0804-y. PMID: 25410750. [PubMed: 25410750] [CrossRef]
110.
Graham UM, McCance DR, Young IS, et al A randomised controlled trial evaluating the effect of potassium supplementation on vascular function and the renin-angiotensinaldosterone system. J Hum Hypertens. 2014 May;28(5):333–9. doi: 10.1038/jhh.2013.89. PMID: 24048291. [PubMed: 24048291] [CrossRef]
111.
Nerbass FB, Pecoits-Filho R, McIntyre NJ, et al Reduction in sodium intake is independently associated with improved blood pressure control in people with chronic kidney disease in primary care. Br J Nutr. 2015 Sep 28;114(6):936–42. doi: 10.1017/s0007114515002494. PMID: 26243465 [PubMed: 26243465] [CrossRef]
112.
Vitolo MR, da Costa Louzada ML, Rauber F, et al Risk factors for high blood pressure in low income children aged 3-4 years. Eur J Pediatr. 2013 Aug;172(8):1097–103. doi: 10.1007/s00431-013-2012-9. PMID: 23636283 [PubMed: 23636283] [CrossRef]
113.
de Brito-Ashurst I, Perry L, Sanders TA, et al The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial. Heart. 2013 Sep;99(17):1256–60. doi: 10.1136/heartjnl-2013-303688. PMID: 23766446. [PMC free article: PMC3756453] [PubMed: 23766446] [CrossRef]
114.
He FJ, Wu Y, Feng XX, et al School based education programme to reduce salt intake in children and their families (School-EduSalt): cluster randomised controlled trial. Bmj. 2015;350:h770. doi: 10.1136/bmj.h770. PMID: 25788018. [PMC free article: PMC4364292] [PubMed: 25788018] [CrossRef]
115.
He FJ, Wu Y, Ma J, et al A school-based education programme to reduce salt intake in children and their families (School-EduSalt): protocol of a cluster randomised controlled trial. BMJ Open. 2013;3(7)doi: 10.1136/bmjopen-2013-003388. PMID: 23864214 [PMC free article: PMC3717470] [PubMed: 23864214] [CrossRef]
116.
Yang Q, Liu T, Kuklina EV, et al Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2011 Jul 11;171(13):1183–91. doi: 10.1001/archinternmed.2011.257. PMID: 21747015 [PubMed: 21747015] [CrossRef]
117.
Joosten MM, Gansevoort RT, Mukamal KJ, et al Sodium excretion and risk of developing coronary heart disease. Circulation. 2014 Mar 11;129(10):1121–8. doi: 10.1161/circulationaha.113.004290. PMID: 24425751. [PubMed: 24425751] [CrossRef]
118.
Mills KT, Chen J, Yang W, et al Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease. Jama. 2016 May 24-31;315(20):2200–10. doi: 10.1001/jama.2016.4447. PMID: 27218629. [PMC free article: PMC5087595] [PubMed: 27218629] [CrossRef]
119.
Araki S, Haneda M, Koya D, et al Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function. Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2152–8. doi: 10.2215/cjn.00980115. PMID: 26563378. [PMC free article: PMC4670758] [PubMed: 26563378] [CrossRef]
120.
Kieneker LM, Gansevoort RT, Mukamal KJ, et al Urinary potassium excretion and risk of developing hypertension: the prevention of renal and vascular end-stage disease study. Hypertension. 2014 Oct;64(4):769–76 doi: 10.1161/hypertensionaha.114.03750. PMID: 25047575 [PubMed: 25047575] [CrossRef]
121.
He J, Mills KT, Appel LJ, et al Urinary Sodium and Potassium Excretion and CKD Progression. J Am Soc Nephrol. 2016 Apr;27(4):1202–12. doi: 10.1681/asn.2015010022. PMID: 26382905. [PMC free article: PMC4814179] [PubMed: 26382905] [CrossRef]
122.
O’Donnell MJ, Yusuf S, Mente A, et al Urinary sodium and potassium excretion and risk of cardiovascular events. Jama. 2011 Nov 23;306(20):2229–38. doi: 10.1001/jama.2011.1729. PMID: 22110105. [PubMed: 22110105] [CrossRef]
123.
Leonberg-Yoo AK, Tighiouart H, Levey AS, et al Urine Potassium Excretion, Kidney Failure, and Mortality in CKD. Am J Kidney Dis. 2016 May 24 doi: 10.1053/j.ajkd.2016.03.431. PMID: 27233381 [PMC free article: PMC6047752] [PubMed: 27233381] [CrossRef]
124.
Zhao X, Yin X, Li X, et al Using a low-sodium, high-potassium salt substitute to reduce blood pressure among Tibetans with high blood pressure: a patient-blinded randomized controlled trial. PLoS One. 2014;9(10):e110131. doi: 10.1371/journal.pone.0110131. PMID: 25338053 [PMC free article: PMC4206289] [PubMed: 25338053] [CrossRef]
125.
Siani A, Strazzullo P, Giacco A, et al Increasing the dietary potassium intake reduces the need for antihypertensive medication. Ann Intern Med. 1991 Nov 15;115(10):753–9. PMID: 1929022. [PubMed: 1929022]
126.
He FJ, Marciniak M, Carney C, et al Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives. Hypertension. 2010 Mar;55(3):681–8. doi: 10.1161/HYPERTENSIONAHA.109.147488. PMID: 20083724. [PubMed: 20083724] [CrossRef]
127.
Berry SE, Mulla UZ, Chowienczyk PJ, et al Increased potassium intake from fruit and vegetables or supplements does not lower blood pressure or improve vascular function in UK men and women with early hypertension: a randomised controlled trial. Br J Nutr. 2010 Dec;104(12):1839–47. doi: 10.1017/S0007114510002904. PMID: 20673378 [PubMed: 20673378] [CrossRef]
128.
Larsson SC, Virtanen MJ, Mars M, et al Magnesium, calcium, potassium, and sodium intakes and risk of stroke in male smokers. Arch Intern Med. 2008 Mar 10;168(5):459–65. doi: 10.1001/archinte.168.5.459. PMID: 18332289. [PubMed: 18332289] [CrossRef]
129.
Geleijnse JM, Witteman JC, Stijnen T, et al Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: the Rotterdam Study. Eur J Epidemiol. 2007;22(11):763–70. doi: 10.1007/s10654-007-9186-2. PMID: 17902026. [PMC free article: PMC2071962] [PubMed: 17902026] [CrossRef]
130.
Cook NR, Obarzanek E, Cutler JA, et al Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention followup study. Arch Intern Med. 2009 Jan 12;169(1):32–40. doi: 10.1001/archinternmed.2008.523. PMID: 19139321. [PMC free article: PMC2629129] [PubMed: 19139321] [CrossRef]
131.
Sinaiko AR, Gomez-Marin O, Prineas RJ. Effect of low sodium diet or potassium supplementation on adolescent blood pressure. Hypertension. 1993 Jun;21(6 Pt 2):989–94. PMID: 8505112. [PubMed: 8505112]
132.
Geleijnse JM, Grobbee DE, Hofman A. Sodium and potassium intake and blood pressure change in childhood. BMJ. 1990 Apr 7;300(6729):899–902. PMID: 2337712. [PMC free article: PMC1662662] [PubMed: 2337712]
133.
Miller JZ, Weinberger MH, Christian JC. Blood pressure response to potassium supplementation in normotensive adults and children. Hypertension. 1987 Oct;10(4):437–42 PMID: 3653972. [PubMed: 3653972]
134.
Cohen HW, Hailpern SM, Fang J, et al Sodium intake and mortality in the NHANES II followup study. Am J Med. 2006 Mar;119(3):275e7–14. doi: 10.1016/j.amjmed.2005.10.042. PMID: 16490476. [PubMed: 16490476] [CrossRef]
135.
Umesawa M, Yamagishi K, Noda H, et al The relationship between sodium concentrations in spot urine and blood pressure increases: A prospective study of Japanese general population: The Circulatory Risk in Communities Study (CIRCS). BMC Cardiovascular Disorders. 2016;16(1) PMID: 20160191132 FULL TEXT LINK http://dx​.doi.org/10​.1186/s12872-016-0219-1. [PMC free article: PMC4779198] [PubMed: 26944259]
136.
Lamelas PM, Mente A, Diaz R, et al Association of urinary sodium excretion with blood pressure and cardiovascular clinical events in 17,033 Latin americans. American Journal of Hypertension. 2016 2016;29(7):796–805. PMID: 20160592429 FULL TEXT LINK http://dx​.doi.org/10.1093/ajh/hpv195. [PMC free article: PMC4901858] [PubMed: 26683344]
137.
Kieneker LM, Gansevoort RT, De Boer RA, et al Urinary potassium excretion and risk of cardiovascular events. American Journal of Clinical Nutrition. 2016 1;103(5):1204–12 PMID: 20160386660 FULL TEXT LINK http://dx​.doi.org/10​.3945/ajcn.115.106773. [PubMed: 26984482]
138.
Catena C, Colussi G, Novello M, et al Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study. Hypertension. 2016 1;68(1):204–12. PMID: 20160430885 FULL TEXT LINK http://dx​.doi.org/10​.1161/HYPERTENSIONAHA.116.07615. [PubMed: 27245179]
139.
Singer P, Cohen H, Alderman M. Assessing the associations of sodium intake with long-term all-cause and cardiovascular mortality in a hypertensive cohort. American Journal of Hypertension. 2015 1;28(3):335–42. PMID: 20160617716 FULL TEXT LINK http://dx​.doi.org/10.1093/ajh/hpu141. [PMC free article: PMC4402347] [PubMed: 25159082]
140.
Seth A, Mossavar-Rahmani Y, Kamensky V, et al Potassium Intake and risk of stroke in women with hypertension and nonhypertension in the women’s health initiative. Stroke. 2014 12;45(10):2874–80. PMID: 2015084736 MEDLINE PMID 25190445 (http://www​.ncbi.nlm.nih​.gov/pubmed/25190445) FULL TEXT LINK http://dx​.doi.org/10​.1161/STROKEAHA.114.006046. [PMC free article: PMC4175295] [PubMed: 25190445]
141.
O’Donnell M, Mente A, Rangarajan S, et al Urinary sodium and potassium excretion, mortality, and cardiovascular events. New England Journal of Medicine. 2014 14;371(7):612–23. PMID: 2014547469 MEDLINE PMID 25119607 (http://www​.ncbi.nlm.nih​.gov/pubmed/25119607) FULL TEXT LINK http://dx​.doi.org/10.1056/NEJMoa1311889. [PubMed: 25119607]
142.
Fan L, Tighiouart H, Levey AS, et al Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney International. 2014 September;86(3):582–8. PMID: 2014594682 FULL TEXT LINK http://dx​.doi.org/10.1038/ki.2014.59. [PMC free article: PMC4149837] [PubMed: 24646858]
143.
McIntyre NJ, Fluck RJ, McIntyre CW, et al Risk profile in chronic kidney disease stage 3: Older versus younger patients. Nephron - Clinical Practice. 2011 November;119(4):C269–C76. PMID: 2011670284 MEDLINE PMID 21921639 (http://www​.ncbi.nlm.nih​.gov/pubmed/21921639) FULL TEXT LINK http://dx​.doi.org/10.1159/000329109. [PubMed: 21921639]
144.
Erratum for Adebamowo et al Association between intakes of magnesium, potassium, and calcium and risk of stroke: 2 cohorts of US women and updated meta-analyses. Am J Clin Nutr 2015;101:1269−77. [PMC free article: PMC4441806] [PubMed: 25948665]
American Journal of Clinical Nutrition. 2015;102(4):981–2. doi: 10.3945/ajcn.115.121319. PMID: 117416111. Language: English. Entry Date: 20151020. Revision Date: 20160815. Publication Type: Article. Journal Subset: Allied Health. [CrossRef]
145.
Shufa D, Neiman A, Batis C, et al Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. American Journal of Clinical Nutrition. 2014;99(2):334–43. doi: 10.3945/ajcn.113.059121. PMID: 104007685. Language: English. Entry Date: 20140124. Revision Date: 20150819. Publication Type: Journal Article. [PMC free article: PMC3893725] [PubMed: 24257724] [CrossRef]
146.
Shi L, Krupp D, Remer T. Salt, fruit and vegetable consumption and blood pressure development: a longitudinal investigation in healthy children. British Journal of Nutrition. 2014;111(4):662–71. doi: 10.1017/S0007114513002961. PMID: 104030014. Language: English. Entry Date: 20140222. Revision Date: 20150710. Publication Type: Journal Article. [PubMed: 24326147] [CrossRef]
147.
Aleksandrova K, Pischon T, Weikert C. Urinary sodium excretion and cardiovascular disease mortality… JAMA. 2011 May 4;305(17):1777–85. [PubMed: 21540421]
JAMA: Journal of the American Medical Association. 2011;306(10):1083–7. doi: 10.1001/jama.2011.1291. PMID: 108260382. Language: English. Entry Date: 20110930. Revision Date: 20150712. Publication Type: Journal Article. [CrossRef]
148.
Cook NR, Cutler JA, Obarzanek E, et al Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational followup of the trials of hypertension prevention (TOHP). Bmj. 2007 Apr 28;334(7599):885–8. doi: 10.1136/bmj.39147.604896.55. PMID: 17449506. [PMC free article: PMC1857760] [PubMed: 17449506] [CrossRef]
149.
Alderman MH, Madhavan S, Cohen H, et al Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995 Jun;25(6):1144–52. PMID: 7768554. [PubMed: 7768554]
150.
Cohen HW, Hailpern SM, Alderman MH. Sodium intake and mortality followup in the Third National Health and Nutrition Examination Survey (NHANES III). J Gen Intern Med. 2008 Sep;23(9):1297–302. doi: 10.1007/s11606-008-0645-6. PMID: 18465175. [PMC free article: PMC2518033] [PubMed: 18465175] [CrossRef]
151.
He J, Ogden LG, Bazzano LA, et al Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Followup Study. Arch Intern Med. 2002 Jul 22;162(14):1619–24. PMID: 12123406. [PubMed: 12123406]
152.
Kieneker LM, Bakker SJL, de Boer RA, et al Low potassium excretion but not high sodium excretion is associated with increased risk of developing chronic kidney disease. Kidney International. 2016 Oct;90(4):888–96. doi: 10.1016/j.kint.2016.07.012. PMID: WOS:000384388800025. [PubMed: 27575557] [CrossRef]
153.
Ferraro PM, Mandel EI, Curhan GC, et al Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones. Clinical Journal of the American Society of Nephrology. 2016 Oct;11(10):1834–44. doi: 10.2215/CJN.01520216. PMID: WOS:000384830500017. [PMC free article: PMC5053786] [PubMed: 27445166] [CrossRef]
154.
Dunkler D, Kohl M, Teo KK, et al Dietary risk factors for incidence or progression of chronic kidney disease in individuals with type 2 diabetes in the European Union. Nephrology Dialysis Transplantation. 2015 Aug;30:76–85. doi: 10.1093/ndt/gfv086. PMID: WOS:000359781800010. [PubMed: 26209742] [CrossRef]
155.
Ohta Y, Tsuchihashi T, Kiyohara K, et al High salt intake promotes a decline in renal function in hypertensive patients: a 10-year observational study. Hypertension Research. 2013 Feb;36(2):172–6. doi: 10.1038/hr.2012.155. PMID: WOS:000316780800016. [PubMed: 23051657] [CrossRef]
156.
Australian National Health and Medical Research Council Management Committee. Australian Dietary Salt Study in mild Hypertension. Study Design, Protocol and Pilot Study. In: Strasser T, Ganten D, eds. Mild hypertension: from drug trials to practice. New York, NY: Raven Press; 1987:165–80.
157.
Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Lancet. 1989 Feb 25;1(8635):399–402. PMID: 2563786. [PubMed: 2563786]
158.
Harsha DW, Sacks FM, Obarzanek E, et al Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial. Hypertension. 2004 Feb;43(2):393–8. doi: 10.1161/01.HYP.0000113046.83819.a2. PMID: 14707154. [PubMed: 14707154] [CrossRef]
159.
Howe PR, Lungershausen YK, Cobiac L, et al Effect of sodium restriction and fish oil supplementation on BP and thrombotic risk factors in patients treated with ACE inhibitors. J Hum Hypertens. 1994 Jan;8(1):43–9. PMID: 8151606. [PubMed: 8151606]
160.
Meland E, Aamland A. Salt restriction among hypertensive patients: modest blood pressure effect and no adverse effects. Scand J Prim Health Care. 2009;27:97–103. [PMC free article: PMC3410469] [PubMed: 19140039]
161.
Nestel PJ, Clifton PM, Noakes M, et al Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist: hip ratio. J Hypertens. 1993 Dec;11(12):1387–94. PMID: 8133020. [PubMed: 8133020]
162.
Puska P, Iacono JM, Nissinen A, et al Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet. 1983 Jan 1;1(8314-5):1–5. PMID: 6129364. [PubMed: 6129364]
163.
Sciarrone SE, Beilin LJ, Rouse IL, et al A factorial study of salt restriction and a lowfat/high-fibre diet in hypertensive subjects. J Hypertens. 1992 Mar;10(3):287–98. PMID: 1315827. [PubMed: 1315827]
164.
Silman AJ, Locke C, Mitchell P, et al Evaluation of the effectiveness of a low sodium diet in the treatment of mild to moderate hypertension. Lancet. 1983 May 28;1(8335):1179–82. PMID: 6133987. [PubMed: 6133987]
165.
Satterfield S, Cutler JA, Langford HG, et al Trials of hypertension prevention. Phase I design. Ann Epidemiol. 1991 Aug;1(5):455–71 PMID: 1669525. [PubMed: 1669525]
166.
Cook NR, Kumanyika SK, Cutler JA, et al Dose-response of sodium excretion and blood pressure change among overweight, nonhypertensive adults in a 3-year dietary intervention study. J Hum Hypertens. 2005 Jan;19(1):47–54. doi: 10.1038/sj.jhh.1001775. PMID: 15343354. [PubMed: 15343354] [CrossRef]
167.
Kumanyika SK, Cook NR, Cutler JA, et al Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. J Hum Hypertens. 2005 Jan;19(1):33–45. doi: 10.1038/sj.jhh.1001774. PMID: 15372064. [PubMed: 15372064] [CrossRef]
168.
Lasser VI, Raczynski JM, Stevens VJ, et al Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995 Mar;5(2):156–64. PMID: 7795834. [PubMed: 7795834]
169.
Weir MR, Yadao AM, Purkayastha D, et al Effects of high- and low-sodium diets on ambulatory blood pressure in patients with hypertension receiving aliskiren. J Cardiovasc Pharmacol Ther. 2010 Dec;15(4):356–63. doi: 10.1177/1074248410377173. PMID: 20876343 [PubMed: 20876343] [CrossRef]
170.
Morgan T, Adam W, Gillies A, et al Hypertension treated by salt restriction. Lancet. 1978 Feb 4;1(8058):227–30. PMID: 74660. [PubMed: 74660]
171.
Whelton PK, Appel LJ, Espeland MA, et al Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998 Mar 18;279(11):839–46. PMID: 9515998. [PubMed: 9515998]
172.
Ellison RC, Capper AL, Stephenson WP, et al Effects on blood pressure of a decrease in sodium use in institutional food preparation: the Exeter-Andover Project. J Clin Epidemiol. 1989;42(3):201–8. PMID: 2709080. [PubMed: 2709080]
173.
Miller JZ, Weinberger MH, Daugherty SA, et al Blood pressure response to dietary sodium restriction in healthy normotensive children. Am J Clin Nutr. 1988 Jan;47(1):113–9. PMID: 3337029. [PubMed: 3337029]
174.
Calabrese EJ, Tuthill RW. The Massachusetts Blood Pressure Study, Part 3. Experimental reduction of sodium in drinking water: effects on blood pressure. Toxicol Ind Health. 1985 Sep;1(1):19–34. PMID: 3842544. [PubMed: 3842544]
175.
Gillum RF, Elmer PJ, Prineas RJ. Changing sodium intake in children. The Minneapolis Children’s Blood Pressure Study. Hypertension. 1981 Nov-Dec;3(6):698–703. PMID: 7298122. [PubMed: 7298122]
176.
Barcelo P, Wuhl O, Servitge E, et al Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993 Dec;150(6):1761–4. PMID: 8230497. [PubMed: 8230497]
177.
Appel LJ, Espeland M, Whelton PK, et al Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Ann Epidemiol. 1995 Mar;5(2):119–29. PMID: 7795830. [PubMed: 7795830]
178.
Appel LJ, Hebert PR, Cohen JD, et al Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995 Mar;5(2):149–55. PMID: 7795833. [PubMed: 7795833]
179.
Bahnson JL, Whelton PK, Appel LJ, et al Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE).). Disease Management and Clinical Outcomes. 1997;1:61−8.
180.
Borhani NO, Tonascia J, Schlundt DG, et al Recruitment in the Hypertension Prevention trial. Hypertension Prevention Trial Research Group. Control Clin Trials. 1989 Sep;10(3 Suppl):30S–9S. PMID: 2680272. [PubMed: 2680272]
181.
Brown KM, Oberman A, Van Natta ML, et al Baseline characteristics in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group. Control Clin Trials. 1989 Sep;10(3 Suppl):40S–64S. PMID: 2680273. [PubMed: 2680273]
182.
Chang HY, Hu YW, Yue CS, et al Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr. 2006 Jun;83(6):1289–96 PMID: 16762939. [PubMed: 16762939]
183.
Espeland MA, Whelton PK, Kostis JB, et al Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly. Arch Fam Med. 1999 May-Jun;8(3):228–36. PMID: 10333818. [PubMed: 10333818]
184.
Forster JL, Jeffery RW, VanNatta M, et al Hypertension prevention trial: do 24-h food records capture usual eating behavior in a dietary change study? Am J Clin Nutr. 1990 Feb;51(2):253–7. PMID: 2407098. [PubMed: 2407098]
185.
Hebert PR, Bolt RJ, Borhani NO, et al Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995 Mar;5(2):130–9. PMID: 7795831. [PubMed: 7795831]
186.
Hollis JF, Satterfield S, Smith F, et al Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995 Mar;5(2):140–8. PMID: 7795832. [PubMed: 7795832]
187.
Hunt SC, Cook NR, Oberman A, et al Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension. 1998 Sep;32(3):393–401. PMID: 9740601. [PubMed: 9740601]
188.
Jeffery RW, French SA, Schmid TL. Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychol. 1990;9(3):315–29. PMID: 2187695. [PubMed: 2187695]
189.
Jeffery RW, Tonascia S, Bjornson-Benson W, et al Treatment in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group. Control Clin Trials. 1989 Sep;10(3 Suppl):65S–83S. PMID: 2680274. [PubMed: 2680274]
190.
Kostis JB, Espeland MA, Appel L, et al Does withdrawal of antihypertensive medication increase the risk of cardiovascular events? Trial of Nonpharmacologic Interventions in the Elderly (TONE) Cooperative Research Group. Am J Cardiol. 1998 Dec 15;82(12):1501–8. PMID: 9874055. [PubMed: 9874055]
191.
Meinert CL, Borhani NO, Langford HG. Design, methods, and rationale in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group. Control Clin Trials. 1989 Sep;10(3 Suppl):1S–29S. PMID: 2680271. [PubMed: 2680271]
192.
Morgan TO, Adams WR, Hodgson M, et al Failure of therapy to improve prognosis in elderly males with hypertension. Med J Aust. 1980 Jul 12;2(1):27–31. PMID: 7432261. [PubMed: 7432261]
193.
Prud’homme GJ, Canner PL, Cutler JA. Quality assurance and monitoring in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group. Control Clin Trials. 1989 Sep;10(3 Suppl):84S–94S. PMID: 2680275. [PubMed: 2680275]
194.
Schmid TL, Jeffery RW, Onstad L, et al Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addict Behav. 1991;16(3-4):151–60. PMID: 2063702. [PubMed: 2063702]
195.
Shah M, Jeffery RW, Laing B, et al Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Hypertension Prevention Trial Research Group. J Am Diet Assoc. 1990 Jan;90(1):69–76 PMID: 2404050. [PubMed: 2404050]
196.
China Salt Substitute Study Collaborative G. Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens. 2007 Oct;25(10):2011–8. doi: 10.1097/HJH.0b013e3282b9714b. PMID: 17885542. [PubMed: 17885542] [CrossRef]
197.
Whelton PK, Babnson J, Appel LJ, et al Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). J Am Geriatr Soc. 1997 Feb;45(2):185–93. PMID: 9033517. [PubMed: 9033517]
198.
Beckmann SL, Os I, Kjeldsen SE, et al Effect of dietary counselling on blood pressure and arterial plasma catecholamines in primary hypertension. Am J Hypertens. 1995 Jul;8(7):704–11. PMID: 7546496. [PubMed: 7546496]
199.
Little P, Kelly J, Barnett J, et al Randomised controlled factorial trial of dietary advice for patients with a single high blood pressure reading in primary care. BMJ. 2004 May 1;328(7447):1054. doi: 10.1136/bmj.38037.435972.EE. PMID: 15082472. [PMC free article: PMC403849] [PubMed: 15082472] [CrossRef]
200.
Takahashi Y, Sasaki S, Okubo S, et al Blood pressure change in a free-living population-based dietary modification study in Japan. J Hypertens. 2006 Mar;24(3):451–8 doi: 10.1097/01.hjh.0000209980.36359.16. PMID: 16467647. [PubMed: 16467647] [CrossRef]
201.
Whelton PK, Hebert PR, Cutler J, et al Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention. Ann Epidemiol. 1992 May;2(3):295–310. PMID: 1342280. [PubMed: 1342280]
202.
Whelton PK, Kumanyika SK, Cook NR, et al Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. Am J Clin Nutr. 1997 Feb;65(2 Suppl):652S–60S. PMID: 9022561. [PubMed: 9022561]
203.
Morgan TO, Myers JB. Hypertension treated by sodium restriction. Med J Aust. 1981 Oct 17;2(8):396–7. PMID: 7033744. [PubMed: 7033744]
204.
Ambrosioni E, Costa FV, Borghi C, et al Effects of moderate salt restriction on intralymphocytic sodium and pressor response to stress in borderline hypertension. Hypertension. 1982 Nov-Dec;4(6):789–94. PMID: 7141605. [PubMed: 7141605]
205.
Beard TC, Cooke HM, Gray WR, et al Randomised controlled trial of a no-added-sodium diet for mild hypertension. Lancet. 1982 Aug 28;2(8296):455–8. PMID: 6125636. [PubMed: 6125636]
206.
Bulpitt CJ, Daymond M, Bulpitt PF, et al Is low salt dietary advice a useful therapy in hypertensive patients with poorly controlled blood pressure? Ann Clin Res. 1984;16 Suppl 43:143–9. PMID: 6398984. [PubMed: 6398984]
207.
Tuthill RW, Calabrese EJ. The Massachusetts Blood Pressure Study, Part 4. Modest sodium supplementation and blood pressure change in boarding school girls. Toxicol Ind Health. 1985 Sep;1(1):35–43. PMID: 3842545. [PubMed: 3842545]
208.
Parker M, Puddey IB, Beilin LJ, et al Twoway factorial study of alcohol and salt restriction in treated hypertensive men. Hypertension. 1990 Oct;16(4):398–406. PMID: 2210807. [PubMed: 2210807]
209.
Singer DR, Markandu ND, Sugden AL, et al Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide. Hypertension. 1991 Jun;17(6 Pt 1):798–803. PMID: 2045142. [PubMed: 2045142]
210.
Jula A, Ronnemaa T, Tikkanen I, et al Responses of atrial natriuretic factor to long-term sodium restriction in mild to moderate hypertension. J Intern Med. 1992 May;231(5):521–9. PMID: 1534832. [PubMed: 1534832]
211.
Redon-Mas J, Abellan-Aleman J, Aranda-Lara P, et al Antihypertensive activity of verapamil: impact of dietary sodium. The VERSAL Study Group. J Hypertens. 1993 Jun;11(6):665–71. PMID: 8397246. [PubMed: 8397246]
212.
Arroll B, Beaglehole R. Salt restriction and physical activity in treated hypertensives. N Z Med J. 1995 Jul 14;108(1003):266–8. PMID: 7637923. [PubMed: 7637923]
213.
Dubbert P, Cushman WC, Meydrech E, et al Effects of dietary instruction and sodium excretion feedback in hypertension clinic patients. Behav Ther. 1995;26:721–32.
214.
Van Buul BJA, Steegers EAP, van der Maten GD, et al Dietary sodium restriction does not prevent gestational hypertension: A Dutch two-center randomized trial. Hypertens in Preg. 1997;16:335–46.
215.
Knuist M, Bonsel GJ, Zondervan HA, et al Low sodium diet and pregnancy-induced hypertension: a multi-centre randomised controlled trial. Br J Obstet Gynaecol. 1998 Apr;105(4):430–4. PMID: 9609271. [PubMed: 9609271]
216.
Wing LM, Arnolda LF, Harvey PJ, et al Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor. Blood Press. 1998 Nov;7(5-6):299–307. PMID: 10321443. [PubMed: 10321443]
217.
Seals DR, Tanaka H, Clevenger CM, et al Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol. 2001 Aug;38(2):506–13. PMID: 11499745. [PubMed: 11499745]
218.
Nowson CA, Morgan TO, Gibbons C. Decreasing dietary sodium while following a self-selected potassium-rich diet reduces blood pressure. J Nutr. 2003 Dec;133(12):4118–23. PMID: 14652358. [PubMed: 14652358]
219.
Rimm EB, Giovannucci EL, Willett WC, et al Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991 Aug 24;338(8765):464–8. PMID: 1678444. [PubMed: 1678444]
220.
Kagan A, Harris BR, Winkelstein W, Jr., et al Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chronic Dis. 1974 Sep;27(7-8):345–64. PMID: 4436426. [PubMed: 4436426]
221.
The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol. 1994 Jan;4(1):1–10. PMID: 8205268. [PubMed: 8205268]
222.
Smith WC, Crombie IK, Tavendale R, et al The Scottish Heart Health Study: objectives and development of methods. Health Bull (Edinb). 1987 Jul;45(4):211–7. PMID: 3497906. [PubMed: 3497906]
223.
Stampfer MJ, Willett WC, Colditz GA, et al A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985 Oct 24;313(17):1044–9. doi: 10.1056/NEJM198510243131703. PMID: 4047106. [PubMed: 4047106] [CrossRef]
224.
Investigators O, Yusuf S, Teo KK, et al Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008 Apr 10;358(15):1547–59. doi: 10.1056/NEJMoa0801317. PMID: 18378520. [PubMed: 18378520] [CrossRef]
225.
Telmisartan Randomised AssessmeNt Study in ACEiswcDI, Yusuf S, Teo K, et al Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008 Sep 27;372(9644):1174–83. doi: 10.1016/S0140-6736(08)61242-8. PMID: 18757085. [PubMed: 18757085] [CrossRef]
226.
Kawasaki T, Itoh K, Uezono K, et al A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol. 1993 Jan;20(1):7–14. PMID: 8432042. [PubMed: 8432042]
227.
Lida M, Ueda K, Okayama A, et al Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year followup of randomly selected population from Japanese -- Nippon data 80. J Hum Hypertens. 2003 Dec;17(12):851–7. doi: 10.1038/sj.jhh.1001602. PMID: 14704729. [PubMed: 14704729] [CrossRef]
228.
Hillege HL, Janssen WM, Bak AA, et al Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001 Jun;249(6):519–26. PMID: 11422658. [PubMed: 11422658]
229.
Joosten MM, Gansevoort RT, Mukamal KJ, et al Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr. 2013 Jun;97(6):1299–306. doi: 10.3945/ajcn.112.054114. PMID: 23485414. [PubMed: 23485414] [CrossRef]
230.
Alli C, Avanzini F, Bettelli G, et al Feasibility of a long-term low-sodium diet in mild hypertension. J Hum Hypertens. 1992 Aug;6(4):281–6. PMID: 1433163. [PubMed: 1433163]
231.
Applegate WB, Miller ST, Elam JT, et al Nonpharmacologic intervention to reduce blood pressure in older patients with mild hypertension. Arch Intern Med. 1992 Jun;152(6):1162–6. PMID: 1599343. [PubMed: 1599343]
232.
Geleijnse JM, Witteman JC, Bak AA, et al Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. Bmj. 1994 Aug 13;309(6952):436–40. PMID: 7920126. [PMC free article: PMC2540967] [PubMed: 7920126]
233.
Grimm RH, Jr., Neaton JD, Elmer PJ, et al The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. N Engl J Med. 1990 Mar 01;322(9):569–74. doi: 10.1056/nejm199003013220901. PMID: 2406601 [PubMed: 2406601] [CrossRef]
234.
Hofman A, Hazebroek A, Valkenburg HA. A randomized trial of sodium intake and blood pressure in newborn infants. Jama. 1983 Jul 15;250(3):370–3. PMID: 6343656. [PubMed: 6343656]
235.
Langford HG, Davis BR, Blaufox D, et al Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group. Hypertension. 1991 Feb;17(2):210–7. PMID: 1671380. [PubMed: 1671380]
236.
Nowson CA, Morgan TO. Change in blood pressure in relation to change in nutrients effected by manipulation of dietary sodium and potassium. Clin Exp Pharmacol Physiol. 1988 Mar;15(3):225–42. PMID: 2856053. [PubMed: 2856053]
237.
Pomeranz A, Dolfin T, Korzets Z, et al Increased sodium concentrations in drinking water increase blood pressure in neonates. J Hypertens. 2002 Feb;20(2):203–7. PMID: 11821704. [PubMed: 11821704]
238.
Steegers EA, Van Lakwijk HP, Jongsma HW, et al (Patho)physiological implications of chronic dietary sodium restriction during pregnancy; a longitudinal prospective randomized study. Br J Obstet Gynaecol. 1991 Oct;98(10):980–7. PMID: 1751444. [PubMed: 1751444]
239.
Suppa G, Pollavini G, Alberti D, et al Effects of a low-sodium high-potassium salt in hypertensive patients treated with metoprolol: a multicentre study. J Hypertens. 1988 Oct;6(10):787–90. PMID: 3058796. [PubMed: 3058796]
240.
Whitten CF, Stewart RA. The effect of dietary sodium in infancy on blood pressure and related factors. Studies of infants fed salted and unsalted diets for five months at eight months and eight years of age. Acta Paediatr Scand Suppl. 1980;279:1–17. PMID: 7001854. [PubMed: 7001854]
241.
Zhou X, Liu JX, Shi R, et al Compound ion salt, a novel low-sodium salt substitute: from animal study to community-based population trial. Am J Hypertens. 2009 Sep;22(9):934–42. doi: 10.1038/ajh.2009.135. PMID: 19661926. [PubMed: 19661926] [CrossRef]
242.
Staessen JA, Wang JG, Brand E, et al Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens. 2001 Aug;19(8):1349–58. PMID: 11518842. [PubMed: 11518842]
243.
Li Y, Zagato L, Kuznetsova T, et al Angiotensin-converting enzyme I/D and alpha-adducin Gly460Trp polymorphisms: from angiotensin-converting enzyme activity to cardiovascular outcome. Hypertension. 2007 Jun;49(6):1291–7. doi: 10.1161/HYPERTENSIONAHA.106.085498. PMID: 17452507. [PubMed: 17452507] [CrossRef]
244.
Beulens JW, Monninkhof EM, Verschuren WM, et al Cohort profile: the EPIC-NL study. Int J Epidemiol. 2010 Oct;39(5):1170–8. doi: 10.1093/ije/dyp217. PMID: 19483199. [PubMed: 19483199] [CrossRef]
245.
Obesity and cardiovascular disease risk factors in black and white girls: the NHLBI Growth and Health Study. Am J Public Health. 1992 Dec;82(12):1613–20. PMID: 1456335. [PMC free article: PMC1694560] [PubMed: 1456335]
246.
Araki S, Haneda M, Koya D, et al Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy. Diabetes Care. 2013 May;36(5):1248–53. doi: 10.2337/dc12-1298. PMID: 23223350. [PMC free article: PMC3631864] [PubMed: 23223350] [CrossRef]
247.
Yang W, Xie D, Anderson AH, et al Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2014 Feb;63(2):236–43. doi: 10.1053/j.ajkd.2013.08.028. PMID: 24182662 [PMC free article: PMC3946885] [PubMed: 24182662] [CrossRef]
248.
Lash JP, Go AS, Appel LJ, et al Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009 Aug;4(8):1302–11. doi: 10.2215/CJN.00070109. PMID: 19541818. [PMC free article: PMC2723966] [PubMed: 19541818] [CrossRef]
249.
Hofman A, Grobbee DE, de Jong PT, et al Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991 Jul;7(4):403–22. PMID: 1833235. [PubMed: 1833235]
250.
Tsai S. The effect of potassium containing salt on blood pressure reduction in Elderly. Master’s Thesis. Taipei: Chinese Culture University; 1996.
251.
UMIN-CTR Clinical Trial: Effect of salt reduction by aggressive nutritional education on clinic, home, and ambulatory BP levels. https://upload​.umin.ac​.jp/cgi-openbin/ctr_e/ctr_view​.cgi?recptno=R000017378.
252.
Gomez-Marin O, Prineas RJ, Sinaiko AR. The Sodium-Potassium Blood Pressure Trial in Children. Design, recruitment, and randomization: the children and adolescent blood pressure program. Control Clin Trials. 1991 Jun;12(3):408–23. PMID: 1651211. [PubMed: 1651211]
253.
Sechi LA, Di Fabio A, Bazzocchi M, et al Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab. 2009 Apr;94(4):1191–7. doi: 10.1210/jc.2008-2245. PMID: 19141581. [PMC free article: PMC2682479] [PubMed: 19141581] [CrossRef]
254.
Catena C, Colussi G, Lapenna R, et al Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007 Nov;50(5):911–8. doi: 10.1161/HYPERTENSIONAHA.107.095448. PMID: 17893375. [PubMed: 17893375] [CrossRef]
255.
Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of followup. J Am Soc Nephrol. 2004 Dec;15(12):3225–32. doi: 10.1097/01.ASN.0000146012.44570.20. PMID: 15579526. [PubMed: 15579526] [CrossRef]
256.
Anderson GL, Manson J, Wallace R, et al Implementation of the Women’s Health Initiative study design. Ann Epidemiol. 2003 Oct;13(9 Suppl):S5–17. PMID: 14575938. [PubMed: 14575938]
257.
Teo K, Yusuf S, Sleight P, et al Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Am Heart J. 2004 Jul;148(1):52–61. doi: 10.1016/j.ahj.2004.03.020. PMID: 15215792. [PubMed: 15215792] [CrossRef]
258.
Catena C, Lapenna R, Baroselli S, et al Insulin sensitivity in patients with primary aldosteronism: a followup study. J Clin Endocrinol Metab. 2006 Sep;91(9):3457–63. doi: 10.1210/jc.2006-0736. PMID: 16822818. [PubMed: 16822818] [CrossRef]
259.
Catena C, Colussi G, Nadalini E, et al Relationships of plasma renin levels with renal function in patients with primary aldosteronism. Clin J Am Soc Nephrol. 2007 Jul;2(4):722–31. doi: 10.2215/CJN.00050107. PMID: 17699488. [PubMed: 17699488] [CrossRef]
260.
Todd AS, Macginley RJ, Schollum JB, et al Dietary salt loading impairs arterial vascular reactivity. Am J Clin Nutr. 2010 Mar;91(3):557–64. doi: 10.3945/ajcn.2009.28645. PMID: 20107199. [PubMed: 20107199] [CrossRef]
261.
Svetkey LP, Simons-Morton DG, Proschan MA, et al Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control. J Clin Hypertens (Greenwich). 2004 Jul;6(7):373–81. PMID: 15249792. [PMC free article: PMC8109350] [PubMed: 15249792]
262.
Saptharishi L, Soudarssanane M, Thiruselvakumar D, et al Community-based Randomized Controlled Trial of Nonpharmacological Interventions in Prevention and Control of Hypertension among Young Adults. Indian J Community Med. 2009 Oct;34(4):329–34. doi: 10.4103/0970-0218.58393. PMID: 20165628. [PMC free article: PMC2822195] [PubMed: 20165628] [CrossRef]
263.
Santos A, Martins MJ, Guimaraes JT, et al Sodium-rich carbonated natural mineral water ingestion and blood pressure. Rev Port Cardiol. 2010 Feb;29(2):159–72. PMID: 20545244. [PubMed: 20545244]
264.
Rahimi ARO, Mhmoodpoor A, Sanaie S. The effect of high-calcium and high-potassium diet on grade-I hypertension and high normal blood pressure. Pakistan Journal of Medical Sciences. 2007;23(4):589–92.
265.
Mu J, Liu Z, Liu F, et al Family-based randomized trial to detect effects on blood pressure of a salt substitute containing potassium and calcium in hypertensive adolescents. Am J Hypertens. 2009 Sep;22(9):943–7. doi: 10.1038/ajh.2009.136. PMID: 19661927. [PubMed: 19661927] [CrossRef]
266.
Meuleman Y, Hoekstra T, Dekker FW, et al Sodium Restriction in Patients With CKD: A Randomized Controlled Trial of Self-management Support. Am J Kidney Dis. 2016 Dec 16 doi: 10.1053/j.ajkd.2016.08.042. PMID: 27993433 [PubMed: 27993433] [CrossRef]
267.
Li N, Yan LL, Niu W, et al The Effects of a Community-Based Sodium Reduction Program in Rural China - A Cluster-Randomized Trial. PLoS One. 2016;11(12):e0166620. doi: 10.1371/journal.pone.0166620. PMID: 27935977 [PMC free article: PMC5147834] [PubMed: 27935977] [CrossRef]
268.
Kojuri J, Rahimi R. Effect of “no added salt diet” on blood pressure control and 24 hour urinary sodium excretion in mild to moderate hypertension. BMC Cardiovasc Disord. 2007 Nov 06;7:34. doi: 10.1186/1471-2261-7-34. PMID: 17986327. [PMC free article: PMC2245976] [PubMed: 17986327] [CrossRef]
269.
Inoue M, Tsuchihashi T, Hasuo Y, et al Salt Intake, Home Blood Pressure, and Perinatal Outcome in Pregnant Women. Circ J. 2016 Sep 23;80(10):2165–72. doi: 10.1253/circj.CJ-16-0405. PMID: 27568849 [PubMed: 27568849] [CrossRef]
270.
Hu J, Jiang X, Li N, et al Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: a randomized controlled trial. Hypertens Res. 2009 Apr;32(4):282–8. doi: 10.1038/hr.2009.7. PMID: 19262499. [PubMed: 19262499] [CrossRef]
271.
Franzoni F, Santoro G, Carpi A, et al Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension. Biomedicine & Pharmacotherapy. 2005 Jan-Feb;59(1-2):25–9. doi: 10.1016/j.biopha.2004.11.002. PMID: WOS:000227959300005. [PubMed: 15740932] [CrossRef]
272.
Curhan GC, Willett WC, Knight EL, et al Dietary factors and the risk of incident kidney stones in younger women: Nurses’ Health Study II. Arch Intern Med. 2004 Apr 26;164(8):885–91. doi: 10.1001/archinte.164.8.885. PMID: 15111375. [PubMed: 15111375] [CrossRef]
273.
Cook NR, Appel LJ, Whelton PK. Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. J Am Coll Cardiol. 2016 Oct 11;68(15):1609–17. doi: 10.1016/j.jacc.2016.07.745. PMID: 27712772 [PMC free article: PMC5098805] [PubMed: 27712772] [CrossRef]
274.
Chien KL, Hsu HC, Chen PC, et al Urinary sodium and potassium excretion and risk of hypertension in Chinese: report from a community-based cohort study in Taiwan. J Hypertens. 2008 Sep;26(9):1750–6. doi: 10.1097/HJH.0b013e328306a0a7. PMID: 18698208. [PubMed: 18698208] [CrossRef]
275.
Charlton KE, Steyn K, Levitt NS, et al A food-based dietary strategy lowers blood pressure in a low socio-economic setting: a randomised study in South Africa. Public Health Nutr. 2008 Dec;11(12):1397–406. doi: 10.1017/s136898000800342x. PMID: 18752692. [PubMed: 18752692] [CrossRef]
276.
Cappuccio FP, Kerry SM, Micah FB, et al A community programme to reduce salt intake and blood pressure in Ghana [ISRCTN88789643]. BMC Public Health. 2006 Jan 24;6:13. doi: 10.1186/1471-2458-6-13. PMID: 16433927. [PMC free article: PMC1382202] [PubMed: 16433927] [CrossRef]
277.
Braschi A, Naismith DJ. The effect of a dietary supplement of potassium chloride or potassium citrate on blood pressure in predominantly normotensive volunteers. Br J Nutr. 2008 Jun;99(6):1284–92. doi: 10.1017/s0007114507864853. PMID: 18053306. [PubMed: 18053306] [CrossRef]
278.
Akita S, Sacks FM, Svetkey LP, et al Effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the pressure-natriuresis relationship. Hypertension. 2003 Jul;42(1):8–13. doi: 10.1161/01.hyp.0000074668.08704.6e. PMID: 12756219. [PubMed: 12756219] [CrossRef]
279.
Prineas RJ, Gillum RF, Horibe H, et al The Minneapolis childrn’s blood pressure study. Part 2: multiple determinants of children’s blood pressure. Hypertension. 1980 Jul-Aug;2(4 Pt 2):I24–8. PMID: 7399637. [PubMed: 7399637]
280.
Sundar S, Sachdev KK, Vaish SK, et al Potassium supplementation in essential hypertension--a double blind placebo controlled study. J Assoc Physicians India. 1985 Dec;33(12):776–7. PMID: 3915499. [PubMed: 3915499]
281.
Cook NR, Kumanyika SK, Cutler JA. Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I. Am J Epidemiol. 1998 Sep 01;148(5):431–44. PMID: 9737555. [PubMed: 9737555]
282.
Gilleran G, O’Leary M, Bartlett WA, et al Effects of dietary sodium substitution with potassium and magnesium in hypertensive type II diabetics: a randomised blind controlled parallel study. J Hum Hypertens. 1996 Aug;10(8):517–21. PMID: 8895035. [PubMed: 8895035]
283.
Flack JM, Grimm RH, Jr., Staffileno BA, et al New salt-sensitivity metrics: variability-adjusted blood pressure change and the urinary sodium-to-creatinine ratio. Ethn Dis. 2002 Winter;12(1):10–9. PMID: 11913598. [PubMed: 11913598]
284.
Xie J, Wang J, Yang H. Hypertension control improved through patient education. Chinese PEP Investigators. Chin Med J (Engl). 1998 Jul;111(7):581–4. PMID: 11246837. [PubMed: 11246837]
285.
Klahr S, Levey AS, Beck GJ, et al The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994 Mar 31;330(13):877–84. doi: 10.1056/NEJM199403313301301. PMID: 8114857. [PubMed: 8114857] [CrossRef]
286.
US Department of Health and Human Services CfDCaP. The Second National Health and Nutrition Examination Survey (1976-1980). Available at: http://www​.cdc.gov/nchs​/data/series/sr_01/sr01_015.pdf. Accessed May 22, 2017. 2005.
287.
Yamamoto ME, Applegate WB, Klag MJ, et al Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995 Mar;5(2):96–107. PMID: 7795837. [PubMed: 7795837]
288.
Kroke A, Manz F, Kersting M, et al The DONALD Study. History, current status and future perspectives. Eur J Nutr. 2004 Feb;43(1):45–54. doi: 10.1007/s00394-004-0445-7. PMID: 14991269. [PubMed: 14991269] [CrossRef]
289.
Juraschek SP, Woodward M, Sacks FM, et al Time course of change in blood pressure from the dash diet and sodium reduction. Circulation. 2017;135(1):2017–03. [PMC free article: PMC5659740] [PubMed: 28993451]
290.
Juraschek SP, Miller ER, 3rd, Weaver CM, et al Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure. J Am Coll Cardiol. 2017 Nov 4 doi: 10.1016/j.jacc.2017.10.011. PMID: 29141784. [PMC free article: PMC5742671] [PubMed: 29141784] [CrossRef]
291.
De Brito-Ashurst L, Perry L, Sanders TAB, et al The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: A randomized controlled trial. Heart. 2013 September;99(17):1256–60. PMID: 2013503824 MEDLINE PMID 23766446 (http://www​.ncbi.nlm.nih​.gov/pubmed/23766446) FULL TEXT LINK http://dx​.doi.org/10​.1136/heartjnl-2013-303688. [PMC free article: PMC3756453] [PubMed: 23766446]
292.
Bompiani GD, Cerasola G, Morici ML, et al Effects of moderate low sodium/high potassium diet on essential hypertension: results of a comparative study. Int J Clin Pharmacol Ther Toxicol. 1988 Mar;26(3):129–32. PMID: 3045025. [PubMed: 3045025]
293.
Taftachi F, Sanaei-Zadeh H, Sepehrian B, et al Lipid emulsion improves Glasgow coma scale and decreases blood glucose level in the setting of acute non-local anesthetic drug poisoning--a randomized controlled trial. Eur Rev Med Pharmacol Sci. 2012 Mar;16 Suppl 1:38–42. PMID: 22582483. [PubMed: 22582483]
294.
Du S, Batis C, Wang H, et al Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr. 2014 Feb;99(2):334–43 doi: 10.3945/ajcn.113.059121. PMID: 24257724. [PMC free article: PMC3893725] [PubMed: 24257724] [CrossRef]
295.
Jankowski P, Stolarz-Skrzypek K, Kawecka-Jaszcz K, et al Does sodium intake affect the relationship between blood pressure and vascular damage? Pol Arch Med Wewn. 2015;125(5):347–57. PMID: 25827590. [PubMed: 25827590]
296.
Effect of reduced sodium intake on blood pressure, renal function, blood lipids and other potential adverse effects World Health Organization. Geneva, Switzerland: 2012. http://apps​.who.int/iris​/bitstream/10665​/79325/1/9789241504911_eng​.pdf?ua=1&ua=1
297.
Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev. 2017 Apr 09;4:CD004022. doi: 10.1002/14651858.CD004022.pub4. PMID: 28391629 [PMC free article: PMC6478144] [PubMed: 28391629] [CrossRef]
298.
Graudal N, Jurgens G, Baslund B, et al Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens. 2014 Sep;27(9):1129–37. doi: 10.1093/ajh/hpu028. PMID: 24651634. [PubMed: 24651634] [CrossRef]
299.
Kwok TCY, Lam LCW, Sea MMM, et al A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition. 2012 October;66(10):1135–40. PMID: 2012584864 MEDLINE PMID 22948946 (http://www​.ncbi.nlm.nih​.gov/pubmed/22948946) FULL TEXT LINK http://dx​.doi.org/10.1038/ejcn.2012.117. [PubMed: 22948946]
300.
McMahon EJ, Campbell KL, Bauer JD, et al Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev. 2015(2):CD010070. doi: 10.1002/14651858.CD010070.pub2. PMID: 25691262 [PubMed: 25691262] [CrossRef]
301.
Aburto NJ, Hanson S, Gutierrez H, et al Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378. doi: 10.1136/bmj.f1378. PMID: 23558164. [PMC free article: PMC4816263] [PubMed: 23558164] [CrossRef]
302.
Juraschek SP, Woodward M, Sacks FM, et al Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet. Hypertension. 2017 Nov;70(5):923–9. doi: 10.1161/hypertensionaha.117.10017. PMID: 28993451 [PMC free article: PMC5659740] [PubMed: 28993451] [CrossRef]
303.
Zhou L, Tian Y, Fu JJ, et al Validation of spot urine in predicting 24-h sodium excretion at the individual level. Am J Clin Nutr. 2017 Jun;105(6):1291–6. doi: 10.3945/ajcn.116.147553. PMID: 28356277. [PubMed: 28356277] [CrossRef]
304.
MacGregor GA, Markandu ND, Best FE, et al Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet. 1982 Feb 13;1(8268):351–5. PMID: 6120346. [PubMed: 6120346]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (13M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...